Search Results for: wto

The Medical Innovation Prize Fund (S.2210, 110th Congress) and the WTO TRIPS Agreement

Posted on by James Love

I have been asked to elaborate on the relationship between the Medical Innovation Prize Fund (S.2210, 110th Congress) and the WTO TRIPS Agreement.

For centuries, innovation inducement prizes have been suggested as a mechanism to stimulate investments in a wide range of topics. (See, for example, Selected Innovation Prizes and Reward Programs, KEI Research Note 2008:1). During most of this period, the patent system has also existed.

Continue Reading →

Uncategorized

European Commission Response to CPTech Letter Regarding EU Opt-out of WTO Compulsory Licensing Mechanism

Posted on by KEI Staff

Original page: http://www.cptech.org/ip/wto/p6/eu12052005.pdf Letter from CPTech referenced available here: https://www.keionline.org/32641 MARKOS KYPRIANOU                                            PETER MANDELSON Member of the European Commission … Continue Reading →

CPTech Letter to USTR Portman Regarding US Position on WTO Opt-Out of Compulsory Licensing Mechanism

Posted on by KEI Staff

Original page: http://www.cptech.org/ip/birdflu/ustr-birdflu.html 14 October 2005 Honorable Rob Portman United States Trade Representative 600 17th Street, N.W. Washington, DC 20508 Dear Ambassador Portman: We are writing to ask that the United States government address a mistake in trade policy that… Continue Reading →

CPTech Statement on WTO Deal on Exports of Medicines

Posted on by KEI Staff

Original page: http://www.cptech.org/ip/wto/p6/cptech08302003.html CPTech Statement on WTO Deal on Exports of Medicines August 30, 2003 “Today’s decision on the implementation of paragraph 6 of the Doha Declaration on TRIPS and Public Health puts the WTO into unchartered waters. The WTO… Continue Reading →

USTR Zoellick Letter to TACD IP Group Regarding WTO Compulsory Licensing Mechanism

Posted on by KEI Staff

Original page: http://www.cptech.org/ip/wto/p6/zoellick02102003.doc RECEIVED 24 FEB 2003 Executive Office of the President The United States Trade Representative Washington, DC 20508 February 10, 2003 Mr. James Love Co-Chair TACD IP-workinggroup TACD Secretariat 24 Highbury Crescent UK-London N5 1RXDear Mr. Love, Thank… Continue Reading →

EC Pascal Lamy Letter in Response to TACD regarding WTO Export Issue

Posted on by KEI Staff

Original: Page 1 – http://www.cptech.org/ip/health/eu/lamy2tacd20mar2002-p1.jpg Page 2 – http://www.cptech.org/ip/health/eu/lamy2tacd20mar2002-p2.jpg Note by James Love on April 1, 2002 via IP-Health email list regarding the letter below (archived link of the note here): This these are scans of Pascal Lamy’s March 20… Continue Reading →

2001: Compulsory Licensing: Models For State Practice In Developing Countries, Access to Medicine and Compliance with the WTO TRIPS Accord

Posted on by James Love

Compulsory Licensing: Models For State Practice In Developing Countries, Access to Medicine and Compliance with the WTO TRIPS Accord Prepared for the United Nations Development Programme January 21, 2001 James Love Consumer Project on Technology http://www.cptech.org Introduction.1 This note addresses… Continue Reading →

1996 Paper on Trade and Pharmaceutical Policies for HAI Seminar on WTO/GATT, Bielefeld Germany

Posted on by James Love

Comments on Trade and Pharmaceutical Policies: A Perspective from the U.S. Consumer Movement HAI Seminar: World Trade Organization/GATT, Pharmaceutical Policies and Essential Drugs October 4, 1996 Bielefeld, Germany James Love Center for Study of Responsive Law (1) I would like… Continue Reading →